Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / ChM sp. z o.o.

Clinicaltrial registered2 Nov 2026

ChM sp. z o.o.

2 Nov 2026: Trial registered · Study Evaluating the Safety and Efficacy of the TMChM Prosthesis in the Treatment of People With Chronic Flexor Tendon Fingers Injuries. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
2 Nov 2026
Title
Study Evaluating the Safety and Efficacy of the TMChM Prosthesis in the Treatment of People With Chronic Flexor Tendon Fingers Injuries
Conditions
Tendon Injuries
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Poland
Country
Poland
Reference
NCT07910123
Location
Poland
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at ChM sp. z o.o.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Poland

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.